Get the Stockscreener App
45.28
1.69%
-0.78
After Hours:
45.28
Qiagen Nv stock is traded at $45.28, with a volume of 974.68K.
It is down -1.69% in the last 24 hours and down -7.54% over the past month.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
See More
Previous Close:
$46.06
Open:
$45.98
24h Volume:
974.68K
Relative Volume:
0.71
Market Cap:
$9.98B
Revenue:
$1.98B
Net Income/Loss:
$83.59M
P/E Ratio:
121.07
EPS:
0.374
Net Cash Flow:
$502.31M
1W Performance:
-4.77%
1M Performance:
-7.54%
6M Performance:
+14.92%
1Y Performance:
-3.40%
1-Day Range:
$45.28
$45.99
1-Week Range:
$45.28
$47.93
52-Week Range:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
45.28 | 9.98B | 1.98B | 83.59M | 502.31M | 0.374 |
|
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-04-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-19-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-06-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-10-24 | Upgrade | Jefferies | Hold → Buy |
| Oct-17-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jun-27-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Dec-07-23 | Upgrade | Goldman | Neutral → Buy |
| Sep-12-23 | Initiated | Robert W. Baird | Outperform |
| May-23-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-18-22 | Upgrade | DZ Bank | Hold → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Oct-14-21 | Initiated | Redburn | Buy |
| Jul-14-21 | Downgrade | Kepler | Buy → Hold |
| Jun-03-21 | Initiated | Goldman | Neutral |
| Oct-06-20 | Resumed | BofA Securities | Buy |
| Sep-28-20 | Upgrade | Kepler | Hold → Buy |
| Aug-24-20 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Aug-17-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-14-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-14-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-04-20 | Downgrade | Berenberg | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Dec-26-19 | Resumed | BofA/Merrill | Underperform |
| Nov-15-19 | Initiated | Stifel | Hold |
| Nov-14-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-14-19 | Upgrade | JP Morgan | Underweight → Overweight |
| Nov-14-19 | Upgrade | Kepler | Reduce → Hold |
| Oct-17-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-09-19 | Downgrade | Kepler | Hold → Reduce |
| Oct-08-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-08-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
View All
Qiagen Nv Stock (QGEN) Latest News
Barclays’ Significant Stake in QIAGEN Revealed by AFM - TipRanks
Cubist Systematic Strategies LLC Sells 25,043 Shares of Qiagen N.V. $QGEN - MarketBeat
Vident Advisory LLC Buys Shares of 15,040 QIAGEN N.V. $QGEN - MarketBeat
Qiagen N.V. (QGEN) Launches QIAseq xHYB Panels for Long-Read Sequencing - uk.finance.yahoo.com
Parkman Healthcare Partners LLC Raises Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen secures European CE-IVDR certification for full Qiastat-Dx portfolio - MarketScreener
QGENQIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels - mx.advfn.com
QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio - sharewise.com
Qiagen (QGEN) Earns CE-IVDR Certification for Advanced Diagnosti - GuruFocus
Transcript : Qiagen N.V. Presents at Baird Global Healthcare Conference 2025, Sep-10-2025 01 - MarketScreener
Nitorum Capital L.P. Makes New $4.42 Million Investment in Qiagen N.V. $QGEN - MarketBeat
QIAGEN Announces Voting Rights Notification by AFM - TipRanks
Edmond DE Rothschild Holding S.A. Has $19.62 Million Stake in QIAGEN N.V. $QGEN - MarketBeat
Qiagen N.V. Announces Voting Rights Notification - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Is Qiagen N.V. stock a smart retirement pickRecession Risk & Risk Adjusted Buy/Sell Alerts - Lancaster City Council
AI Trend Models Suggest Bounce for Qiagen N.V.2025 Trade Ideas & Long-Term Growth Portfolio Plans - beatles.ru
Ucleic Acid Amplification Testing Market Set for Dynamic - openPR.com
Perbak Capital Partners LLP Lowers Stock Position in QIAGEN N.V. $QGEN - MarketBeat
PDT Partners LLC Reduces Holdings in Qiagen N.V. $QGEN - MarketBeat
What’s next for Qiagen N.V. stockJuly 2025 Closing Moves & Technical Confirmation Trade Alerts - beatles.ru
Qiagen N.V. Announces Voting Rights Notification by AFM - The Globe and Mail
Qiagen N.V. $QGEN Shares Bought by Graham Capital Management L.P. - MarketBeat
Can swing trading help recover from Qiagen N.V. lossesWeekly Trend Recap & Accurate Technical Buy Alerts - Newser
Is Qiagen N.V. forming a bullish divergenceJuly 2025 Selloffs & Smart Allocation Stock Tips - 강소기업뉴스
What are analysts’ price targets for Qiagen N.V.July 2025 Breakouts & Accurate Buy Signal Alerts - خودرو بانک
BNP Paribas Financial Markets Decreases Stake in Qiagen N.V. $QGEN - MarketBeat
Analyzing recovery setups for Qiagen N.V. investorsBond Market & Verified High Yield Trade Plans - Newser
Qiagen N.V. stock prediction for this weekJuly 2025 Short Interest & AI Enhanced Execution Alerts - Newser
Oncology Molecular Diagnostics Market Size Drives USD 9.76 Billion by 2034 - GlobeNewswire Inc.
Is Qiagen N.V. still worth holding after the dipPortfolio Value Report & Safe Entry Momentum Tips - Newser
RNA Editing Market Top PlayersQIAGEN N.V., UniquQuire NV, LAVA - openPR.com
Raymond James Financial Inc. Sells 26,000 Shares of QIAGEN N.V. $QGEN - MarketBeat
Real time social sentiment graph for Qiagen N.V.July 2025 Pullbacks & High Yield Stock Recommendations - Newser
QIAGEN NV : Jefferies reaffirms its Buy rating - MarketScreener
What analysts say about Qiagen N.V. stock2025 Macro Impact & Free Real-Time Market Sentiment Alerts - خودرو بانک
QGEN Stock Likely to Gain From Innovation Amid Competition - MSN
Investors in Qiagen (NYSE:QGEN) have unfortunately lost 4.9% over the last five years - Yahoo Finance
Chart based analysis of Qiagen N.V. trendsWeekly Risk Summary & Daily Technical Forecast Reports - Newser
Charles Schwab Investment Management Inc. Sells 124,875 Shares of QIAGEN N.V. $QGEN - MarketBeat
Qiagen N.V. stock trend forecastChart Signals & Entry Point Confirmation Alerts - Newser
Will Qiagen N.V. outperform the market2025 Market Trends & Long Hold Capital Preservation Plans - Newser
Does Qiagen N.V. meet Warren Buffett’s criteria2025 Geopolitical Influence & Verified Short-Term Plans - خودرو بانک
Long term hold vs stop loss in Qiagen N.V.Weekly Profit Summary & Long Hold Capital Preservation Tips - Newser
Will Qiagen N.V. stock go up soonWeekly Trend Recap & Stock Portfolio Risk Control - Newser
Volatility Watch: What are analysts’ price targets for Qiagen N.V.July 2025 Weekly Recap & Verified Trade Idea Suggestions - خودرو بانک
Is Qiagen N.V. stock a good dividend stockPortfolio Profit Report & Long-Term Safe Investment Ideas - خودرو بانک
Is Qiagen N.V. stock showing strong momentumJuly 2025 Review & Low Risk High Reward Trade Ideas - خودرو بانک
Multi asset correlation models including Qiagen N.V.Earnings Beat & Technical Buy Zone Confirmation - Newser
QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise - TradingView
FDA clears Qiagen’s next-gen syndrome panel - Medical Device Network
Qiagen Nv Stock (QGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):